Myocardial renin is neither necessary nor sufficient to initiate or maintain ventricular hypertrophy

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Katz, Stephen A ^a,b   Opsahl, John A ^a   Wernsing, Shane E ^a   Forbis, Lynn M ^b   Smith, Juline ^a   Heller, Lois J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Cardiac growth; Deoxycorticosterone acetate; Losartan; Low salt diet; Renin angiotensin system

Indexed keywords

ANGIOTENSINOGEN; LOSARTAN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE COURSE; HEART; HEART VENTRICLE HYPERTROPHY; HORMONE DETERMINATION; MEASUREMENT; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RESTRICTION;

EID: 0034058093     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.3.r578     Document Type: Article

References (45)

1. Boer, P. H., M. Ruzicka, W. Lear, E. Harmsen, J. Rosenthal, and F. H. H. Leenen. Stretch-mediated activation of cardiac renin gene. Am. J. Physiol. Heart Circ. Physiol. 267: H1630-H1636, 1994.
2. Buttrick, P., M. Kaplan, M. J. F. Camargo, G. deSimone, J. H. Laragh, D. Wallerson, and R. B. Devereux. The influence of dietary salt and plasma renin activity on myosin heavy chain gene expression in rat hearts. Am. J. Hypertens. 6: 579-585, 1993.
3. Chen, K., X. Zhang, E. W. Dunham, and B. G. Zimmerman. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension. Hypertension 27: 85-89, 1996.
4. Collister, J. P., and J. W. Osborn. Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 274: R357-R366, 1998.
5. Dahlof, B., K. Pennert, and L. Hansson. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am. J. Hypertens. 5: 95-110, 1992.
6. Danser, A. H. J., J. P. van Kats, P. J. J. Admiraal, F. H. M. Derkz, J. M. J. Lamers, P. D. Verdouw, P. R. Saxena, and M. A. D. H. Schalekamp. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 24: 37-48, 1994.
7. Danser, A. H. J., C. A. M. van Kesteren, W. A. Bax, M. Tavenier, F. H. M. Derkx, P. R. Saxena, and M. A. D. H. Schalekamp. Prorenin, renin, angiotensinogen, and angiotensin-converting enxyme in normal and failing human hearts; evidence for renin binding. Circulation 96: 220-226, 1997.
8. De Lannoy, L. M., A. H. J. Danser, J. P. van Kats, R. G. Schoemaker, P. R. Saxena, and M. A. D. H. Schalekamp. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Hypertension 29: 1240-1251, 1997.
9. De Simone, G., R. B. Devereux, M. J. F. Camargo, D. C. Wallerson, J. E. Sealey, and J. H. Laragh. Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition. Am. J. Hypertens. 9: 216-222, 1996.
10. 1 receptor. Am. J. Hypertens. 5: 276-280, 1992.
11. 1 expression. Hypertension 23: 587-592, 1994.
12. Fink, G. D., C. M. Pawloski, M. L. Blair, and M. L. Mangiapane. The area postrema in deoxycorticosterone-salt hypertension in rats. Hypertension 9: III206-III209, 1987.
13. Gavras, H. Angiotensin-converting enzyme inhibition and the heart. Hypertension 23: 813-818, 1994.
14. Geenen, D. L., A. Malhotra, and P. M. Buttrick. Angiotensin receptor 1 blockade does not prevent physiological cardiac hypertrophy in the adult rat. J. Appl. Physiol. 81: 816-821, 1996.
15. Griffin, S. A., W. C. B. Brown, F. MacPherson, J. C. McGrath, V. G. Wilson, N. Korsgaard, M. J. Mulvany, and A. F. Lever. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991.
16. Haddad, F., P. W. Bodell, and K. M. Baldwin. Pressure-induced regulation of myosin expression in rodent heart. J. Appl. Physiol. 78: 1489-1495, 1995.
17. 1A receptors. Am. J. Physiol. Heart Circ. Physiol. 274: H868-H873, 1998.
18. Heller, L. J., J. A. Opsahl, S. E. Wernsing, R. Saxena, and S.A. Katz. Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 274: R849-R856, 1998.
19. Hirsch, A. T., C. E. Talsness, H. Schunkert, M. Paul, and V. J. Dzau. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ. Res. 69: 475-482, 1991.
20. Jennings, G., and J. Wong. Regression of left ventricular hypertrophy in hypertension: changing patterns with successive meta-analysis. J. Hypertens. 16, Suppl. 6: S29-S34, 1998.
21. Kang, P. M., A. Nakouzi, T. Simpson, J. Scheuer, and P. M. Buttrick. Role of endogenous renin-angiotensin system in c-fos activation and PKC-e translocation in adult rat hearts. Am. J. Physiol. Heart Circ. Physiol. 270: H2177-H2183, 1996.
22. Katz, S. A., J. A. Opsahl, M. M. Lunzer, L. M. Forbis, and A. T. Hirsch. Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension 30: 259-266, 1997.
23. Lindpaintner, K., and D. Ganten. The cardiac renin-angiotensin system. Circ. Res. 68: 905-921, 1991.
24. Lindpaintner, K., M. Jin, N. Niedermaier, M. J. Wilhelm, and D. Ganten. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ. Res. 67: 564-573, 1990.
25. Lindpaintner, K., W. Lu, N. Niedermaier, B. Schieffer, H. Just, D. Ganten, and H. Drexler. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J. Mol. Cell. Cardiol. 25: 133-143, 1993.
26. Lonn, E. M., S. Yusuf, P. Jha, T. J. Montague, K. K. Teo, C. R. Benedict, and B. Pitt. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 90: 2056-2069, 1994.
27. Lui, Y. H., X. P. Yang, V. G. Sharov, O. Nass, H. N. Sabbah, E. Peterson, and O. A. Carretero. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type I receptor antagonists in rats with heart failure - role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 99: 1926-1935, 1997.
28. Mazzolai, L., J. Nussberger, J.-F. Aubert, D. B. Brunner, G. Gabbiani, H. R. Brunner, and T. Pedrazzini. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 31: 1324-1330, 1998.
29. Nakamura, F., M. Nagano, J. Higaki, K. Higashimori, R. Morishita, H. Mikami, and T. Ogihara. The angiotensin-converting enzyme inhibitor, perindopril, prevents cardiac hypertrophy in low-renin hypertensive rats. Clin. Exp. Pharmacol. Physiol. 20: 135-140, 1993.
30. Nishikimi, T., H. Yamagishi, K. Takeuchi, and T. Takeda. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat. Cardiovasc. Res. 29: 856-861, 1995.
31. Ramires, F. J. A., Y. Sun, and K. T. Weber. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade. J. Mol. Cell. Cardiol. 30: 475-483, 1998.
32. 1 receptor subtype. Circ. Res. 73: 413-423, 1993.
33. Sadoshima, J., Y. Xu, H. S. Slayter, and S. Izumo. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993.
34. Schieffer, B., A. Wirger, M. Meybrunn, S. Seitz, J. Holtz, U. N. Riede, and H. Drexler. Comparative effects of chronic angiotensin converting enzyme inhibition and angiotensin II receptor blockade on cardiac remodeling after cardiac infarction in the rat. Circulation 89: 2273-2282, 1994.
35. Schunkert, H., J. Sadoshima, T. Cornelius, Y. Kagaya, E. O. Weinberg, S. Izumo, G. Riegger, and B. H. Lorell. Angiotensin II-induced growth responses in isolated adult rat hearts. Circ. Res. 76: 489-497, 1995.
36. Smith, R. D., A. T. Chiu, P. C. Wong, W. F. Herblin, and P. B. M. W. M. Timmermans. Pharmacology of nonpeptide angiotensin II receptor antagonists. Ann. Rev. Pharmacol. Toxicol. 32: 135-165, 1992.
37. Stula, M., Y. M. Pinto, S. Gschwend, A. C. Teisman, W. H. van Gilst, M. Böhm, R. Dietz, and M. Paul. Interaction of the renin-angiotensin system and endothelin system in cardiac hypertrophy. J. Cardiovasc. Pharm. 31: S403-S405, 1998.
38. Sugimoto, K., E. Gotoh, I. Takasaki, T. Ebina, T. Iwamoto, T. Takizawa, H. Shionoiri, and M. Ishii. AT(1) receptor antagoist, TCV 116, does not prevent cardiac hypertrophy in salt-loaded Dahl salt-sensitive rats. Clin. Exp. Pharmacol. Physiol. 23: 282-286, 1996.
39. Susic, D., E. Nuñez, E. D. Frohlich, and O. Prakash. Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension 28: 265-268, 1996.
40. Swoap, S. J., P. Boddell, and K. M. Baldwin. Interaction of hypertension and caloric restriction on cardiac mass and isomysin expression. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 268: R33-R39, 1995.
41. Von Lutterotti, N., D. F. Catanzaro, J. E. Sealey, and J. H. Laragh. Renin is not synthesized by cardiac and extrarenal vascular tissues. Circulation 89: 458-470, 1994.
42. Wada, H., M. R. Zile, C. T. Ivestor, G. Cooper IV, and P. J. McDermott. Comparative effects of contraction and angiotensin II on growth of adult feline cardiocytes in primary culture. Am. J. Physiol. Heart Circ. Physiol. 271: H29-H37, 1996.
43. Weber, K. T., Y. Sun, and S. E. Campbell. Structural remodelling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides. Eur. Heart J. 16: N12-N18, 1995.
44. Young, M. J., and J. W. Funder. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis. Am. J. Physiol. Endocrinol. Metab. 271: E883-E888, 1996.
45. Zhang, X., D. E. Dostal, K. Reiss, W. Cheng, J. Kajstura, P. Li, H. Huang, E. H. Sonnenblick, L. G. Meggs, K. M. Baker, and P. Anversa. Identification and activation of autorine renin-angiotensin system in adult ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 269: H1791-H1802, 1995.